Human CCL2/JE/MCP-1 Antibody Summary
Gln24-Thr99
Accession # P13500
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
CCL2/JE/MCP‑1 in Human Breast Cancer Tissue. CCL2/JE/MCP-1 was detected in immersion fixed paraffin-embedded sections of human breast cancer tissue using 25 µg/mL Mouse Anti-Human CCL2/JE/MCP-1 Monoclonal Antibody (Catalog # MAB2791) overnight at 4 °C. Tissue was stained with the Anti-Mouse HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS002) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CCL2/JE/MCP-1
MCP-1 is a beta -chemokine that has been designated CCL2. It is produced by a variety of cell types and is chemotactic for monocytes.
Product Datasheets
Citations for Human CCL2/JE/MCP-1 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
20
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy
Authors: Triulzi T, Forte L, Regondi V et al.
OncoImmunology
-
Extreme Diversity of the Human Vascular Mesenchymal Cell Landscape
Authors: LE Bruijn, BEWM van den Ak, CM van Rhijn, JF Hamming, JHN Lindeman
J Am Heart Assoc, 2020-11-16;9(23):e017094.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Appropriate Surgical Treatment of Symptomatic Primary Varicose Veins Decreases Systemic Inflammatory Biomarkers
Authors: Hiroki Arase, Noriko Sugasawa, Youhei Kawatani, Mikio Sugano, Hirotsugu Kurobe, Eiki Fujimoto et al.
Annals of Vascular Diseases
-
Chronic Inflammation Directs an Olfactory Stem Cell Functional Switch from Neuroregeneration to Immune Defense
Authors: M Chen, RR Reed, AP Lane
Cell Stem Cell, 2019-09-12;25(4):501-513.e5.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-Fr -
Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-?B signaling
Authors: R Han, S Gu, Y Zhang, A Luo, X Jing, L Zhao, X Zhao, L Zhang
Sci Rep, 2018-06-22;8(1):9575.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Human Parvovirus Infection of Human Airway Epithelia Induces Pyroptotic Cell Death by Inhibiting Apoptosis
Authors: Xuefeng Deng, Wei Zou, Min Xiong, Zekun Wang, John F. Engelhardt, Shui Qing Ye et al.
Journal of Virology
-
An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium.
Authors: Rump L, Mattey D, Kehoe O, Middleton J
Cytokine, 2017-09-01;97(0):133-140.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-Fr -
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
Authors: Maike Hartlage-Rübsamen, Alexander Waniek, Juliane Meissner, Markus Morawski, Stephan Schilling, Carsten Jäger et al.
Acta Neuropathologica
-
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
Authors: Marloes Prins, Ranjan Dutta, Bart Baselmans, John J P Brevé, John G J M Bol, Sadie A Deckard et al.
Acta Neuropathologica Communications
-
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
Authors: Bonapace L, Coissieux M, Wyckoff J, Mertz K, Varga Z, Junt T, Bentires-Alj M
Nature, 2014-10-22;515(7525):130-3.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis
Authors: Shervin Assassi, Minghua Wu, Filemon K. Tan, Jeffrey Chang, Tiffany A. Graham, Daniel E. Furst et al.
Arthritis & Rheumatism
-
Impact of Tumor Vascularity on Responsiveness to Anti-angiogenesis in a Prostate Cancer Stem Cell-derived Tumor Model
Authors: Kexiong Zhang, David J. Waxman
Molecular Cancer Therapeutics
-
Aberrant expression of selectin E, CXCL1, and CXCL13 in chronic endometritis
Authors: Kotaro Kitaya, Tadahiro Yasuo
Modern Pathology
-
The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells
Authors: Colm Morrissey, Janice S. Lai, Lisha G. Brown, Ya-Chun Wang, Martine P. Roudier, Ilsa M. Coleman et al.
The Prostate
-
Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.
Authors: Weigt SS, Elashoff RM, Keane MP, Strieter RM, Gomperts BN, Xue YY, Ardehali A, Gregson AL, Kubak B, Fishbein MC, Saggar R, Ross DJ, Lynch JP, Zisman DA, Belperio JA
Am. J. Transplant., 2008-07-01;8(7):1512-22.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Exploring human testicular peritubular cells: identification of secretory products and regulation by tumor necrosis factor-alpha.
Authors: Schell C, Albrecht M, Mayer C, Schwarzer JU, Frungieri MB, Mayerhofer A
Endocrinology, 2008-01-10;149(4):1678-86.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes.
Authors: Burt D, Salvidio G, Tarabra E, Barutta F, Pinach S, Dentelli P, Camussi G, Perin PC, Gruden G
Am. J. Pathol., 2007-11-30;171(6):1789-99.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load.
Authors: Pulliam L, Sun B, Rempel H
J. Neuroimmunol., 2004-12-01;157(1):93-8.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer
Authors: Choi YW, Kim YH, Oh SY et al.
Advanced Science
-
Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.
Authors: Jenkins B D, Martini R N et al.
Cancer Epidemiol Biomarkers Prev
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CCL2/JE/MCP-1 Antibody
Average Rating: 5 (Based on 1 Review)
Have you used Human CCL2/JE/MCP-1 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: